Paul Tudor Jones II acquired 38.4 Thousand Viridian Therapeutics shares worth $490 Thousand. That's 0.01% of their equity portfolio (1128th largest holding). The first Viridian Therapeutics trade was made in Q1 2023. Since then Paul Tudor Jones II bought shares three more times and sold shares on two occasions. The investor's estimated purchase price is $609 Thousand, resulting in a loss of 19%.